Status:
COMPLETED
Neurological Fate, Prematurity and Genetic Susceptibility Factors
Lead Sponsor:
Nantes University Hospital
Conditions:
Polymorphism, Restriction Fragment Length
Premature
Eligibility:
All Genders
5-12 years
Brief Summary
This study could help identify aggravating or protective genetic polymorphisms associated with cerebral palsy. Populations of premature babies at different risk of cerebral palsy could thus be individ...
Eligibility Criteria
Inclusion
- children born prematurely at term \<34 weeks between 2008 and 2015
- assessed at the age of 2 within the Growing Together Network in Pays de Loire
- parental consent for the collection of data from their child and for intraoral sampling for the search for genetic factors.
Exclusion
- children who died after the age of 2
- children who refused and / or whose parents refused to participate in the study
Key Trial Info
Start Date :
March 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 9 2022
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04298346
Start Date
March 9 2020
End Date
March 9 2022
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Nantes
Nantes, France, 44000